Accessibility Menu
Medline logo

Medline(NASDAQ) MDLN

Market Cap$32.10BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2025)-11%
5 YearN/A
1 YearN/A
1 Month-0%
$36.56
-0.10%
-0.04Today
After hours$36.55-$0.01 (-0.01%)
Medline last closing stock price
MetricPriceDate
Last closeUSD 36.592026-09-04
Medline stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+3.71%USD 35.282026-08-28
1 month-0.2%USD 36.672026-08-05
3 month+8.87%USD 33.612026-06-05
Year to date-12.88%USD 42.002025-12-31
Since inception-10.76%USD 41.002025-12-17

Medline Financials at a Glance

Market Cap

$32.10BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$29.94B

Net Income (TTM)

$691.00M

EPS (TTM)

$0.85

P/E Ratio

42.91

Dividend

$0.00

Beta (Volatility)

0.05 (Low)

Price

$36.56

Volume

5,244,069.409

Open

$36.20

Previous Close

$36.59

Daily Range

$36.04 - $36.99

52-Week Range

$29.00 - $50.88

Estimated Earnings Date

Nov 4, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Medline

Medline Inc. makes and ships medical supplies to healthcare providers. It helps hospitals and doctor offices get the tools they need. The company provides everything from surgical gloves to lab equipment.

What's in the Box?

  • Supply Chain Solutions: Distribution of third-party products and logistics services; accounts for 53.9% of total net sales for the three-month period ended June 27, 2026.
  • Surgical Solutions: Operating room products including trays, drapes, gowns, and implants; part of the Medline Brand segment which accounts for 46.1% of total net sales for the same period.
  • Frontline Care: Patient-facing items like wound care treatments, exam gloves, and nursing supplies; part of the Medline Brand segment.
  • Laboratory and Diagnostics: Clinical testing equipment, monitoring systems, and lab consumables; part of the Medline Brand segment.

Strategic Moves and New Sites

  • Completed an initial public offering on Dec. 18, 2025.
  • Executed secondary public offerings of Class A common stock in March and May 2026.
  • Entered lease agreements for two new distribution centers in Northern California in June 2026.
  • Expanded manufacturing facilities in Mexico and other regions during the first half of fiscal year 2026.

A Connected Care Network

Medline operates a Prime Vendor model supported by a specialized distribution network and commercial platform. The company maintains vertically integrated manufacturing and a sourcing footprint to manage global supply chain challenges.

Measuring Recent Performance

  • Net sales reached $7.7 billion for the three-month period ended June 27, 2026, up 11.6% year over year.
  • Net income was $139 million for the three-month period ended June 27, 2026, down 58.3% year over year.
  • Adjusted EBITDA, which the company uses to assess performance by removing non-core items, hit $1.1 billion for the three-month period ended June 27, 2026.
  • Total indebtedness was $12.8 billion as of June 27, 2026, including senior secured and unsecured notes.

The Big Picture

Medline has transitioned from a private entity to a public company while expanding its role as a primary distributor and manufacturer for the healthcare industry. Its integrated supply chain and product breadth help stabilize operations across diverse care settings.

AI Generated • Aug 6, 2026

Industry

Healthcare Equipment and Supplies

Employees

45,000

CEO

James M. Boyle

Headquarters

Northfield, IL 60093, US

MDLN Financials

Key Financial Metrics (TTM)

Gross Margin

25.02%

Operating Margin

6.07%

Net Income Margin

2.31%

Return on Equity

5.45%

Return on Capital

9.49%

Return on Assets

1.76%

Earnings Yield

2.33%

Dividend Yield

0.00%

Payout Ratio

13.89%

Stock Overview

Market Cap

$32.10BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

877.35M

Volume

5.24M

Avg. Volume

7.78M

Financials (TTM)

Gross Profit

$7.49B

Operating Income

$1.82B

EBITDA

$2.55B

Operating Cash Flow

$1.99B

Capital Expenditure

$34.00M

Free Cash Flow

$2.03B

Cash & ST Invst.

$2.68B

Total Debt

$12.64B

Medline Performance Analysis

Medline annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 21,448,000,000N/A
20232023-12-31USD 23,231,000,0008.3%
20242024-12-31USD 25,507,000,0009.8%
20252025-12-31USD 28,432,000,00011.5%
Medline sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-303.3%
Q42025-12-319.4%
Q12026-03-31-5.6%
Q22026-06-304.5%
Medline annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.03N/A
20232023-12-31USD 0.29N/A
20242024-12-31USD 1.50412.8%
20252025-12-31USD 1.43-4.9%
Medline sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-2.4%
Q42025-12-31-46.3%
Q12026-03-31-27.3%
Q22026-06-30-56.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$7.69B

+11.6%

Gross Profit

$2.22B

+28.1%

Gross Margin

28.82%

N/A

Market Cap

$32.10BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$713.38K

N/A

Employees

45,000

N/A

Net Income

$60.00M

-82.0%

EBITDA

$659.00M

-21.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$2.68B

+358.4%

Total Debt

$12.64B

-24.1%

Accounts Receivable

$3.66B

+9.6%

Inventory

$4.67B

+0.1%

Long Term Debt

$12.55B

-24.0%

Short Term Debt

$92.00M

-36.6%

Return on Assets

1.76%

N/A

Return on Invested Capital

4.96%

N/A

Free Cash Flow

$604.00M

+486.4%

Operating Cash Flow

$715.00M

+194.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RMDResMed Inc.
$228.35-0.37%
COOThe Cooper Companies, Inc.
$69.59-1.49%
AVTRAvantor, Inc.
$14.97-1.45%
BLCOBausch + Lomb Corporation
$18.04-0.55%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.15-0.12%
NVDANvidia
$230.36+0.01%
PATHUiPath
$15.19-0.17%
INTCIntel
$95.80+0.05%

Questions About MDLN

What is the current price of Medline?

Medline is trading at $36.59 per share.

What is the 52-week range for Medline?

Over the past 52 weeks, Medline has traded between $29.00 and $50.88.

How much debt does Medline have?

As of the most recent reporting period, Medline reported total debt of $12.64B.

How much cash does Medline have on hand?

Medline reported $2.33B in cash and cash equivalents in its most recent financial results.

What is Medline’s dividend yield?

Medline does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.